Importer of Controlled Substances, Notice of Application, Stepan Company, 27935-27936 [2014-11240]
Download as PDF
<![CDATA[
27935
Federal Register / Vol. 79, No. 94 / Thursday, May 15, 2014 / Notices
Commission is properly sought will be
treated accordingly. A redacted nonconfidential version of the document
must also be filed simultaneously with
the any confidential filing. All nonconfidential written submissions will be
available for public inspection at the
Office of the Secretary and on EDIS.
This action is taken under the
authority of section 337 of the Tariff Act
of 1930, as amended (19 U.S.C. 1337),
and of sections 201.10 and 210.50 of the
Commission’s Rules of Practice and
Procedure (19 CFR 201.10, 210.50).
By order of the Commission.
Issued: May 9, 2014.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2014–11128 Filed 5–14–14; 8:45 am]
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
[USITC SE–14–014]
Government in the Sunshine Act
Meeting Notice
United
States International Trade Commission.
AGENCY HOLDING THE MEETING:
TIME AND DATE:
May 21, 2014 at 11:00
a.m.
Room 101, 500 E Street SW.,
Washington, DC 20436, Telephone:
(202) 205–2000.
PLACE:
STATUS:
Open to the public.
TKELLEY on DSK3SPTVN1PROD with NOTICES
MATTERS TO BE CONSIDERED:
1. Agendas for future meetings: none
2. Minutes
3. Ratification List
4. Vote in Inv. No. 731–TA–1143
(Review) (Small Diameter Graphite
Electrodes from China). The
Commission is currently scheduled
to complete and file its
determination and views of the
Commission on June 2, 2014.
5. Outstanding action jackets: none
In accordance with Commission
policy, subject matter listed above, not
disposed of at the scheduled meeting,
may be carried over to the agenda of the
following meeting.
By order of the Commission.
Issued: May 12, 2014.
William R. Bishop,
Supervisory Hearings and Information
Officer.
[FR Doc. 2014–11307 Filed 5–13–14; 11:15 am]
DEPARTMENT OF JUSTICE
To submit comments:
Send them to:
Notice of Lodging of an Amendment to
Consent Decree Under the Clean Air
Act
By mail ......................
Assistant Attorney
General, U.S.
DOJ—ENRD, P.O.
Box 7611, Washington, DC 20044–
7611.
On May 9, 2014, the Department of
Justice lodged with the United States
District Court for the Southern District
of Illinois a proposed Fourth
Amendment to the consent decree in the
lawsuit entitled United States et al v.
Lafarge North America, et al., Civil
Action No. 3:10–cv–44–JPG.
The consent decree, which was
entered by the Court on March 18, 2010,
resolves claims of the United States and
twelve states or state agencies against
Lafarge North America, Inc., Lafarge
Midwest, Inc., and Lafarge Building
Materials, Inc. (‘‘Lafarge’’) for alleged
violations of the Clean Air Act (‘‘CAA’’
or ‘‘Act’’) at its thirteen Portland cement
production facilities in the United
States. The proposed Fourth
Amendment affects only two of the
thirteen cement plants addressed in the
Consent Decree: The Sugar Creek,
Missouri cement plant and the Tulsa,
Oklahoma cement plant. As of
November 30, 2012, the Lafarge
Companies have transferred ownership
and operation of the Sugar Creek and
Tulsa plants to Audubon Materials LLC
and Tulsa Cement LLC, respectively. If
approved by the Court, the Fourth
Amendment would substitute Audubon
Materials LLC for the Lafarge
Companies at the Sugar Creek, Missouri
plant, and would substitute Tulsa
Cement LLC for the Lafarge Companies
at the Tulsa, Oklahoma plant. Audubon
Materials LLC, Tulsa Cement LLC, and
their parent, Eagle Materials Inc.
(collectively, ‘‘the Eagle Companies’’)
have agreed in writing to assume the
obligations, rights, and benefits of, and
to be bound by the terms and conditions
of, the Consent Decree, to the extent
those terms and conditions relate to the
Sugar Creek and Tulsa Cement plants.
The publication of this notice opens
a period for public comment on the
Fourth Amendment. Comments should
be addressed to the Assistant Attorney
General, Environment and Natural
Resources Division, and should refer to
United States et al v. Lafarge North
America, et al., Civil Action No. 3:10–
cv–44–JPG, D.J. Ref No. 90–5–2–1–
08221. All comments must be submitted
no later than thirty (30) days after the
publication date of this notice.
Comments may be submitted either by
email or by mail:
To submit comments:
Send them to:
By e-mail ...................
pubcomment-ees.
enrd@usdoj.gov.
BILLING CODE 7020–02–P
VerDate Mar<15>2010
18:55 May 14, 2014
Jkt 232001
PO 00000
Frm 00099
Fmt 4703
Sfmt 4703
During the public comment period,
the proposed Fourth Amendment may
be examined and downloaded at this
Justice Department Web site: https://
www.usdoj.gov/enrd/
Consent_Decrees.html. We will provide
a paper copy of the proposed Fourth
Amendment upon written request and
payment of reproduction costs. Please
mail your request and payment to:
Consent Decree Library, U.S. DOJ—
ENRD, P.O. Box 7611, Washington, DC
20044–7611.
Please enclose a check or money order
for $12.75 (25 cents per page
reproduction cost) payable to the United
States Treasury. For a paper copy
without the exhibits and signature
pages, the cost is $9.00.
Maureen Katz,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
[FR Doc. 2014–11151 Filed 5–14–14; 8:45 am]
BILLING CODE 4410–15–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances,
Notice of Application, Stepan
Company
Pursuant to 21 CFR 1301.34(a), this is
notice that on February 18, 2014, Stepan
Company, Natural Products Department,
100 W. Hunter Avenue, Maywood, New
Jersey 07607, made application by
renewal to the Drug Enforcement
Administration (DEA) for registration as
an importer of Coca Leaves (9040), a
basic class of controlled substance listed
in schedule II.
The company plans to import the
listed controlled substance to
manufacture bulk controlled substance
for distribution to its customer.
Comments and requests for hearings
on applications to import narcotic raw
material are not appropriate. 72 FR 3417
(January 25,2007).
As noted in a previous notice
published in the Federal Register on
September 23, 1975, 40 FR 43745, all
applicants for registration to import a
basic class of any controlled substance
in schedules I or II are, and will
continue to be, required to demonstrate
to the Deputy Assistant Administrator,
E:\FR\FM\15MYN1.SGM
15MYN1
27936
Federal Register / Vol. 79, No. 94 / Thursday, May 15, 2014 / Notices
Office of Diversion Control, Drug
Enforcement Administration, that the
requirements for such registration
pursuant to 21 U.S.C. 958(a); 21 U.S.C.
823(a); and 21 CFR 1301.34(b), (c), (d),
(e), and (f) are satisfied.
Dated: May 1, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2014–11240 Filed 5–14–14; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
(other than final orders in connection
with suspension, denial, or revocation
of registration) has been re-delegated to
the Deputy Assistant Administrator of
the DEA Office of Diversion Control
(‘‘Deputy Assistant Administrator’’)
pursuant to sec. 7(g) of 28 CFR part 0,
subpart R, App.
In accordance with 21 CFR
1301.33(a), this is notice that on
November 26, 2013, Siemens Healthcare
Diagnostics, Inc., Attn: RA, 100 GBC
Drive, Mail Stop 514, Newark, Delaware
19702, applied to be registered as a bulk
manufacturer of the following basic
classes of narcotic or non-narcotic
controlled substances:
Drug Enforcement Administration
Controlled substance
[Docket No. DEA–392]
Tetrahydrocannabinols (7370) .....
Ecgonine (9180) ...........................
Morphine (9300) ...........................
Bulk Manufacturer of Controlled
Substances Application: SIEMENS
Healthcare Diagnostics, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before July 14, 2014.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, and
dispensers of controlled substances
DATES:
Schedule
I
II
II
The company plans to produce the
listed controlled substances in bulk to
be used in the manufacture of reagents
and drug calibrator controls which are
DEA exempt products.
In reference to drug code 7370 the
company plans to bulk manufacture a
synthetic tetrahydrocannabinol. No
other activity for this drug code is
authorized for this registration.
Dated: May 2, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014–11112 Filed 5–14–14; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before July 14, 2014.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, and
dispensers of controlled substances
(other than final orders in connection
with suspension, denial, or revocation
of registration) has been re-delegated to
the Deputy Assistant Administrator of
the DEA Office of Diversion Control
(‘‘Deputy Assistant Administrator’’)
pursuant to sec. 7(g) of 28 CFR part 0,
subpart R, App.
In accordance with 21 CFR
1301.33(a), this is notice that on March
17, 2014, Alltech Associates, Inc., 2051
Waukegan Road, Deerfield, Illinois
60015, applied to be registered as a bulk
manufacturer of the following basic
classes of narcotic or non-narcotic
controlled substances:
SUPPLEMENTARY INFORMATION:
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Alltech
Associates, Inc.
ACTION:
Notice of application.
TKELLEY on DSK3SPTVN1PROD with NOTICES
Controlled substance
Schedule
Methcathinone (1237) ..................................................................................................................................................................................
N-Ethylamphetamine (1475) ........................................................................................................................................................................
N,N-Dimethylamphetamine (1480) ..............................................................................................................................................................
4-Methylaminorex (cis isomer) (1590) .........................................................................................................................................................
Gamma Hydroxybutyric Acid (2010) ...........................................................................................................................................................
Alpha-ethyltryptamine (7249) ......................................................................................................................................................................
Lysergic acid diethylamide (7315) ...............................................................................................................................................................
2C-T-7 (2,5-Dimethoxy-4-(n)- ......................................................................................................................................................................
propylthiophenethylamine) (7348) ...............................................................................................................................................................
Tetrahydrocannabinols (7370) .....................................................................................................................................................................
Mescaline (7381) .........................................................................................................................................................................................
2C-T-2 (2-(4-Ethylthio-2,5-dimethoxyphenyl)ethanamine) (7385) ...............................................................................................................
4-Bromo-2,5-dimethoxyamphetamine (7391) ..............................................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine (7392) ..........................................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine (7395) ..............................................................................................................................................
2,5-Dimethoxyamphetamine (7396) ............................................................................................................................................................
VerDate Mar<15>2010
18:18 May 14, 2014
Jkt 232001
PO 00000
Frm 00100
Fmt 4703
Sfmt 4703
E:\FR\FM\15MYN1.SGM
15MYN1
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
]]>Agencies
[Federal Register Volume 79, Number 94 (Thursday, May 15, 2014)]
[Notices]
[Pages 27935-27936]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-11240]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances, Notice of Application, Stepan
Company
Pursuant to 21 CFR 1301.34(a), this is notice that on February 18,
2014, Stepan Company, Natural Products Department, 100 W. Hunter
Avenue, Maywood, New Jersey 07607, made application by renewal to the
Drug Enforcement Administration (DEA) for registration as an importer
of Coca Leaves (9040), a basic class of controlled substance listed in
schedule II.
The company plans to import the listed controlled substance to
manufacture bulk controlled substance for distribution to its customer.
Comments and requests for hearings on applications to import
narcotic raw material are not appropriate. 72 FR 3417 (January
25,2007).
As noted in a previous notice published in the Federal Register on
September 23, 1975, 40 FR 43745, all applicants for registration to
import a basic class of any controlled substance in schedules I or II
are, and will continue to be, required to demonstrate to the Deputy
Assistant Administrator,
[[Page 27936]]
Office of Diversion Control, Drug Enforcement Administration, that the
requirements for such registration pursuant to 21 U.S.C. 958(a); 21
U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
Dated: May 1, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2014-11240 Filed 5-14-14; 8:45 am]
BILLING CODE 4410-09-P
